| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.5M | +145.3% |
| R&D Expense | $339.4M | +2.8% |
| SG&A Expense | $215.3M | +24.0% |
| Operating Income | -$536.2M | -8.1% |
| Interest Expense | $37.7M | +33.2% |
| Income Tax | $0 | — |
| Net Income | -$589.5M | -12.0% |
| EPS (Basic) | -$5.26 | +3.5% |
| EPS (Diluted) | -$5.26 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.9M | -16.1% |
| Accounts Receivable | $16.6M | +1197.7% |
| Current Assets | $1.11B | +76.4% |
| Total Assets | $1.40B | +70.0% |
| Current Liabilities | $179.7M | +75.0% |
| Long-term Debt | $619.5M | -3.1% |
| Total Liabilities | $1.54B | +27.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$395.9M | +4.5% |
| Capital Expenditures | $3.9M | +175.8% |
| Investing Cash Flow | -$553.1M | -331.2% |
| Financing Cash Flow | $930.6M | +320.5% |
| Free Cash Flow | -$399.8M | +3.8% |
| +3.5% |
| Stockholders' Equity |
| -$135.4M |
| +65.0% |